Biotech · Private company
LTZ Therapeutics, Inc.
Track this companyFree. Adds LTZ Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- LTZ-232Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- LTZ-301Phase 1 · Non-Hodgkin Lymphoma Refractory/ RelapsedClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid TumorsPHASE1 · RECRUITING · started Oct 28, 2026ClinicalTrials.gov NCT07878988 · fetched Nov 12, 2026
- This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin LymphomaPHASE1 · RECRUITING · started Jan 29, 2026ClinicalTrials.gov NCT07121946 · fetched Nov 12, 2026